mutations to be at least 1.14% based on the gnomAD and ExAC databases. Phenotypic variability was found to be associated with the functional regions and the degree of loss of function of the PATL2 protein. The estimated allele and carrier frequencies were higher than those previously predicted based on clinical ascertainment. The authors reanalyzed data on pathogenic PATL2 mutant lineages in 34 patients identified by other authors and reported that 53.81% of the oocytes with PATL2 mutations were arrested at the germinal vesicle (GV) stage, 9.22% at the metaphase I (MI) stage, and 14.72% at the first polar body stage. In a case report, Zhang et al. identified a complex heterozygous mutation in the PADI6 gene (c.1247T>C; c.2009_2010del), which caused arrest in embryos resulting from 13 MII oocytes at the 1-or 2-cell stage.Diminished ovarian reserve (DOR) is one of the significant causes of FI, which can ultimately lead to POI. Li et al. conducted whole exome sequencing to explore pathogenic variants associated with DOR in twenty young women under 35 years old who were affected by DOR without definite factors damaging ovarian reserve. They identified a set of mutated genes that may be related to DOR, with particular interest in a missense variant in the GPR84 gene, which was further studied. It was found that this variant promoted the expression of proinflammatory cytokines (TNF-α, IL12B, IL-1β) and chemokines (CCL2, CCL5), as well as the activation of the NF-κB signaling pathway, suggesting a mechanism for non-age-related pathological DOR.Li et al. conducted an association study to investigate the relationship between Calpain10 (CAPN10) polymorphisms and susceptibility to PCOS. CAPN10 is the first identified susceptibility gene for type 2 diabetes mellitus and is closely related to insulin sensitivity. Insulin resistance plays a crucial role in the pathogenesis of PCOS. The authors analyzed the genotype and allele frequencies of two CAPN10 polymorphisms (SNP-43 and SNP-44) in a cohort of PCOS patients and healthy controls. They found a significant association between the CAPN10 SNP-43 polymorphism and PCOS susceptibility, suggesting that this genetic variant may contribute to the development of PCOS by affecting insulin sensitivity.In a systematic review and meta-analysis, Chen et al. summarized the current evidence on the association between genetic variants in the estrogen receptor alpha (ESR1) gene and endometriosis risk. Endometriosis is a common gynecological disorder characterized by the presence of endometrial-like tissue outside the uterus. Estrogen signaling is known to play a critical role in the pathogenesis of endometriosis. The authors conducted a comprehensive literature search and identified 18 studies that met the inclusion criteria. Their analysis revealed a significant association between the ESR1 PvuII polymorphism and endometriosis risk in the overall population. Subgroup analyses based on ethnicity suggested that this association might be more pronounced in Asian populations. These findings provide valuable insights into the genetic basis of endometriosis and may have implications for risk assessment and personalized treatment strategies. Some genetic etiologies are shared in both sexes. Jiang et al. reported a novel variant of DNAAF4 in Primary ciliary dyskinesia (PCD). DNAAF4 has been previously reported in male and female infertility. PCD is a rare autosomal recessive disorder that affects the structure and function of motile cilia, leading to classic clinical phenotypes, such as situs inversus, chronic sinusitis, bronchiectasis, repeated pneumonia and infertility. They explored the effect of the mutation on DNAAF4 protein from three aspects: protein expression, stability and interaction with downstream DNAAF2 protein through a series of experiments, such as transfection of plasmids and Coimmunoprecipitation. They confirmed that the mutation of DNAAF4 led to PCD by reducing the stability of DNAAF4 protein, but the expression and function of DNAAF4 protein had not been affected.In conclusion, although some genes like PATL2 and CAPN10 could be highlighted in FI, a wide variety of genes play a role in each phenotype or in a specific subphenotype of FI. Some genes might contribute to both male and FI. More investigations are still needed to find major genetic contributors in FI. This Research Topic highlights the importance of genetics in understanding the etiology and pathogenesis of FI. The studies included in this collection provide novel insights into the genetic factors implicated in various conditions associated with FI, such as oocyte maturation arrest, diminished ovarian reserve, PCOS, and endometriosis. The identification of specific genetic variants associated with these conditions can enhance our understanding of the underlying mechanisms and facilitate the development of targeted diagnostic and therapeutic approaches. However, further research is still needed to unravel the complex genetic architecture of FI and to identify additional susceptibility genes and pathways involved. Continued efforts in this field will contribute to improved clinical management and personalized treatment options for women affected by infertility.
10 Authors
- NL
Na Li
School of Medicine, China
- WX
Wanxue Xu
Department of Obstetrics and Gynecology, China
- HL
Huimin Liu
School of Medicine, China
- RZ
Rui Zhou
School of Medicine, China
- SZ
Siqi Zou
School of Medicine, China
- SW
Shiqing Wang
School of Medicine, China
- SL
Siyu Li
School of Medicine, China
- ZY
Zexin Yang
Graduate school, China
- YP
Yongjun Piao
School of Medicine, China
- YZ
Yunshan Zhang
School of Medicine, China
5 Authors
- TZ
Ting Zhang
Hebei Key Laboratory of Reproductive Medicine, China
- PL
Peng Liu
Hebei Key Laboratory of Reproductive Medicine, China
- GY
Guanfeng Yao
Hebei Key Laboratory of Reproductive Medicine, China
- XZ
Xin Zhang
Hebei Key Laboratory of Reproductive Medicine, China
- CC
Cuijuan Cao
Hebei Key Laboratory of Reproductive Medicine, China
8 Authors
- MH
Mingzhu Huo
Center for Reproductive Medicine, China
- YZ
Yile Zhang
Center for Reproductive Medicine, China
- SS
Senlin Shi
Center for Reproductive Medicine, China
- HS
Hao Shi
Center for Reproductive Medicine, China
- YL
Yidong Liu
Center for Reproductive Medicine, China
- LZ
Lingyun Zhang
Center for Reproductive Medicine, China
- YW
Yanchi Wang
Center for Reproductive Medicine, China
- WN
Wenbin Niu
Center for Reproductive Medicine, China



